Sea Moss and Brain Health: Iodine, Iron, and Why Mineral Deficiency Affects Cognition

Most brain health supplements focus on nootropics — compounds that directly enhance neurotransmission. Sea moss works differently: it addresses the mineral deficiencies that degrade brain function in the first place.

Iodine: The Most Preventable Cause of Cognitive Impairment

The WHO identifies iodine deficiency as the world's leading preventable cause of cognitive impairment. In adults, this isn't just about severe deficiency — subclinical thyroid disruption from marginal iodine status produces brain fog, slowed processing speed, memory difficulty, and depression-adjacent mood states. Thyroid hormones regulate adult neurogenesis in the hippocampus, synaptic plasticity, myelination maintenance, and neurotransmitter enzyme function. Sea moss provides 200-400+ mcg iodine per tablespoon — meaningful relative to the 150 mcg/day adult RDA and often sufficient to address marginal iodine status.

Iron and the Myelin Sheath

Myelin is the fatty insulating sheath around nerve axons that determines signal conduction speed. Iron is a cofactor for the enzyme systems that synthesize and maintain myelin. Non-anemic iron deficiency (normal hemoglobin, low ferritin below 30 ng/mL) is associated with reduced cognitive performance, impaired attention, and slowed processing speed in multiple studies — even without full anemia. The brain has extremely high iron demand for its metabolic rate. Sea moss provides non-heme iron (~0.8-1.2mg/tbsp) as a dietary contribution — pair with vitamin C at every dose for 2-3x better absorption.

Fucoidan and Neuroinflammation

Neuroinflammation is increasingly implicated in cognitive decline, depression, and neurodegenerative conditions. Fucoidan's NF-κB inhibitory activity extends to the central nervous system — animal studies show reduced microglial activation (the brain's resident immune cells) in neuroinflammation models. This is mechanistic support for fucoidan as a dietary anti-neuroinflammatory compound, not a claim about treating neurodegenerative disease.